| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 04/03/1997 | CA2232669A1 Recombinant viruses incorporating a protease cleavable protein |
| 04/03/1997 | CA2231735A1 Materials and methods relating to the transfer of nucleic acid into quiescent cells |
| 04/03/1997 | CA2230933A1 Lantibiotic mutants and chimeras of enhanced stability and activity |
| 04/03/1997 | CA2230121A1 Product and process to regulate actin polymerization |
| 04/03/1997 | CA2229263A1 Peptide derivatives, their production and use |
| 04/02/1997 | EP0765936A1 Cloning of mite allergens |
| 04/02/1997 | EP0765479A1 Method of detecting cancer involving fragments of cytokeratin 18 and corresponding antibodies |
| 04/02/1997 | EP0765478A1 Positive and positive/negative cell selection mediated by peptide release |
| 04/02/1997 | EP0765403A1 System to detect protein-rna interactions |
| 04/02/1997 | EP0765396A1 Locus control subregions for integration-site independent transgene expression |
| 04/02/1997 | EP0765395A1 N-terminally extended proteins expressed in yeast |
| 04/02/1997 | EP0765393A1 Dna molecules which code for a plastid 2-oxoglutarate/malate translocator |
| 04/02/1997 | EP0765391A1 Cloning and expression of an acetylcholine-gated ion channel receptor subunit |
| 04/02/1997 | EP0765390A1 Alpha-lactalbumin gene constructs |
| 04/02/1997 | EP0765389A1 Novel cell systems having specific interaction of peptide binding pairs |
| 04/02/1997 | EP0765343A1 MONOCLONAL ANTIBODY ACTIVE AGAINST CD44v6 |
| 04/02/1997 | EP0765342A1 Methods of producing effective recombinant serine protease inhibitors and uses of these inhibitors |
| 04/02/1997 | EP0765337A1 The production of hemoglobin having a delta-like globin |
| 04/02/1997 | EP0765169A1 Pigment epithelium-derived factor: characterization, genomic organization and sequence of the pedf gene |
| 04/02/1997 | EP0765167A1 Suppression of tumor cell growth by syndecan-1 ectodomain |
| 04/02/1997 | EP0765166A1 Radiolabeled annexin-galactose conjugates |
| 04/02/1997 | EP0765165A1 Constrained peptides |
| 04/02/1997 | EP0765164A1 A PURIFIED 80 kDa PROTEIN IMPLICATED IN ABDOMINAL AORTIC ANEURYSMS, ANTIBODIES DIRECTED THERETO, AND USES THEREOF |
| 04/02/1997 | EP0765125A1 Process for the fractionation of whey constituents |
| 04/02/1997 | EP0654085B1 Monomeric and dimeric antibody-fragment fusion proteins |
| 04/02/1997 | EP0535048B1 Use of derivatives of human bile-salt stimulated lipase for the preparation of medicaments |
| 04/02/1997 | EP0528856B1 Processes and intermediates for synthetic antibody derivatives |
| 04/02/1997 | EP0436597B1 Generation and selection of recombinant varied binding proteins |
| 04/02/1997 | CN1146771A Piptide fragments and analogs derived from pBAN 1-33 NHz for controlling moths |
| 04/02/1997 | CN1146724A Heparin-binding protein for the treatment of sepsis and processes for its preparation |
| 04/02/1997 | CN1146723A Thrombolytic enzyme and method of obtaining same |
| 04/02/1997 | CN1034428C Expression and secretion heterogenous protein with yarrowia lipolytica yeast transformant |
| 04/02/1997 | CN1034427C Method of producing peptides, recombinant plasmid for use in same and animal cells transformed with same |
| 04/02/1997 | CN1034426C Cucumber mosaic virus coat protein gene |
| 04/01/1997 | US5616699 A dna encoding a protein having the activity of interferon regulatory factor-1 that binds to a human interferon gene and augments transcription |
| 04/01/1997 | US5616693 Process for seperating alpha-1-proteinase inhibitor from COHN IV1 +1V4 paste |
| 04/01/1997 | US5616691 Process for producing albumin preparation |
| 04/01/1997 | US5616688 Macrophage-derived inflammatory mediator (MIP-1α and MIP-1β) |
| 04/01/1997 | US5616686 Polypeptide of a hybrid surface protein by bacteria |
| 04/01/1997 | US5616685 snRNP-A antigen and fragments thereof |
| 04/01/1997 | US5616684 Cyclic hexapeptide containing aspartic acid and derivatives, 2-thienylglycine, leucine, and tryptophan; endothelin receptor antagonist |
| 04/01/1997 | US5616564 Antiparasitic oligonucleotides active against drug resistant malaria |
| 04/01/1997 | US5616559 Genetic engineered polypeptide viricides inhibiting virus transcription and replication |
| 04/01/1997 | US5616558 Medicaments comprising glicentin as active ingredient |
| 04/01/1997 | US5616555 Crystalline r-h-GM-CSF and method |
| 04/01/1997 | US5616554 Immune-enhancing agent for therapeutic use in immunocompromised hosts |
| 04/01/1997 | US5616500 Trichohyalin and transglutaminase-3 and methods of using same |
| 04/01/1997 | US5616495 Insecticides; pesticides; controlling ants; genes encoding protein isolates |
| 04/01/1997 | US5616491 Knockout mice |
| 04/01/1997 | US5616490 Enzymatic rna molecule which specifically cleaves messenger rna produced from gene encoding tumor necrosis factor-alpha; treating psoriasis |
| 04/01/1997 | US5616489 DNA sequence which binds transcriptional regulatory proteins activated in response to various cytokines and uses thereof |
| 04/01/1997 | US5616488 IL-5 targeted ribozymes |
| 04/01/1997 | US5616485 Genetic engineering |
| 04/01/1997 | US5616482 Protein fragments including an enzyme fragment a of diphtheria toxin bound together and also bound to a polypeptide ligand able to bind to selected cells; antitumor and carcinogenic agents |
| 04/01/1997 | US5616481 Genetic engineered dna technology in neurobiology |
| 04/01/1997 | US5616477 Fusion proteins comprising GM-CSF and antigens and their expression in yeast |
| 04/01/1997 | US5616476 Synthetic isohirudins with improved stability |
| 04/01/1997 | US5616475 Human T-cell leukemia virus transcription modulators and screening assays |
| 04/01/1997 | US5616474 K. lactis transaldolase gene promoter and use thereof |
| 04/01/1997 | US5616472 Process for producing monoclonal antibodies against human T cell receptor elements using recombinant DNA vectors, and cells transfected thereby |
| 04/01/1997 | US5616468 Compositions and diagnostic methods using monoclonal antibodies against CD44v6 |
| 04/01/1997 | US5616463 Stimulating cells with ionizing radiation, comparing level of gadd45 messenger rna in stimulated cells to that in unstimulated cells |
| 04/01/1997 | US5616327 M-protein peptides of influenza virus as antiviral agents |
| 04/01/1997 | US5616323 Cucumis melo protein extract with antioxidant activity and process for preparing it, cosmetic or pharmaceutical composition or food composition containing such an extract |
| 04/01/1997 | US5616322 Sperm antigen corresponding to a sperm zona binding protein autoantigenic epitope |
| 04/01/1997 | US5616319 Bacillus thuringiensis cryET5 gene and related plasmids, bacteria and insecticides |
| 04/01/1997 | CA1339046C Proteins having growth hormone anabolic properties with reduced effect on carbohydrate metabolism |
| 04/01/1997 | CA1339045C Crystalline human proinsulin and process for its production |
| 04/01/1997 | CA1339044C Insulin derivatives, the use thereof, and a pharmaceutical composition containing them |
| 04/01/1997 | CA1339043C Nonapeptide and decapetide analogs of lhrh useful as lhrh antagonists |
| 04/01/1997 | CA1339033C Glycopeptide antibiotics a82846 from nocardia orientalis |
| 04/01/1997 | CA1339032C Forms of colony stimulating factor-1 |
| 03/30/1997 | CA2159532A1 Dna constructs and methods for screening for increased expression of human apo ai gene |
| 03/27/1997 | WO1997011192A1 Dna encoding medicinal proteins |
| 03/27/1997 | WO1997011190A2 Dna construct comprising a muscle specific regulatory element for immunization or gene therapy |
| 03/27/1997 | WO1997011188A1 Plants which synthesise a modified starch, process for the production thereof and modified starch |
| 03/27/1997 | WO1997011187A1 Subtilisin inhibitor of streptomyces venezuelae, and use of the gene sequences for expression and/or secretion of heterologous proteins in streptomyces |
| 03/27/1997 | WO1997011186A1 Process for producing natriuretic peptides via streptavidine fusion proteins |
| 03/27/1997 | WO1997011183A1 Streptavidin mutants |
| 03/27/1997 | WO1997011182A1 New adhesin from helicobacter pylori |
| 03/27/1997 | WO1997011181A1 Nucleic acid molecules which code proteins which mediate the adhesion of neisseria cells to human cells |
| 03/27/1997 | WO1997011180A1 Leishmania antigens for use in the therapy and diagnosis of leishmaniasis |
| 03/27/1997 | WO1997011179A2 VARIANTS OF HUMAN RECOMBINANT INTERFERON-η (RHU-IFN-η) HAVING INCREASED HEAT-STABILITY |
| 03/27/1997 | WO1997011178A1 Human growth hormone variants |
| 03/27/1997 | WO1997011176A2 Cyclin/cdk associated proteins, and uses related thereto |
| 03/27/1997 | WO1997011175A1 Screening for disorders of serotonergic dysfunction |
| 03/27/1997 | WO1997011174A1 Cyclin depenpent kinase binding compounds |
| 03/27/1997 | WO1997011173A2 Nucleic acid molecule encoding tgf receptor having modified growth inhibition, and its use |
| 03/27/1997 | WO1997011169A2 Strategy for suppressing the expression of an endogeneous gene by using compounds that are able to bind to the non-coding regions of the gene to be suppressed |
| 03/27/1997 | WO1997011168A1 Promoter and uses thereof |
| 03/27/1997 | WO1997011160A1 Method of adsorbing viruses from fluid compositions |
| 03/27/1997 | WO1997011159A1 Yeast receptor and g-protein fusion protein |
| 03/27/1997 | WO1997011095A1 Uses of bone morphogenetic proteins |
| 03/27/1997 | WO1997011094A1 Novel variants of green fluorescent protein, gfp |
| 03/27/1997 | WO1997011093A2 Parainfluenza virus glycoproteins and vaccines |
| 03/27/1997 | WO1997011091A1 Novel peptide compounds and medicinal compositions thereof |
| 03/27/1997 | WO1997011090A1 Inhibition of tumor growth |
| 03/27/1997 | WO1997011089A1 Treatment of patients with idiopathic dilated cardiomyopathy |
| 03/27/1997 | WO1997011088A1 Novel genes mapping in the digeorge and velocardiofacial syndrome minimal critical region |
| 03/27/1997 | WO1997011086A1 High level expression of proteins |